CAS 83249-56-3

Ethyl N-acetyl-3,5-diiodo-O-(4-methoxyphenyl)-L-tyrosinate

Codes: Levothyroxine Sodium-020

Application context (from source-drug indications)

ComaLevothyroxine Sodium粘液性水肿昏迷Levothyroxine SodiumHypothyroidismLevothyroxine SodiumThyroid cancerLevothyroxine SodiumHyperthyroidismLevothyroxine SodiumObesityLevothyroxine Sodium

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Levothyroxine Sodium	Tier B — Position early	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Levothyroxine SodiumOptimised routesteps: 1total yield: 4.9g(Levothyroxine Sodium-020)

Ethyl N-acetyl-3,5-diiodo-L-tyrosinate→Bis(4-methoxyphenyl)iodanium tetrafluoridoborate(1-)→Ethyl N-acetyl-3,5-diiodo-O-(4-methoxyphenyl)-L-tyrosinate

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.